- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 9/51 - Nanocapsules
Détention brevets de la classe A61K 9/51
Brevets de cette classe: 8383
Historique des publications depuis 10 ans
|
480
|
538
|
585
|
683
|
733
|
748
|
823
|
906
|
1027
|
449
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Modernatx, Inc. | 1254 |
261 |
| The Regents of the University of California | 19752 |
161 |
| The Johns Hopkins University | 5612 |
115 |
| Massachusetts Institute of Technology | 9967 |
94 |
| Yale University | 2341 |
82 |
| Translate bio, Inc. | 410 |
78 |
| Abraxis BioScience, LLC | 209 |
65 |
| Board of Regents, The University of Texas System | 5725 |
63 |
| Northwestern University | 3337 |
60 |
| Selecta Biosciences, Inc. | 189 |
55 |
| The Board of Regents of the University of Texas System | 2184 |
53 |
| BioNTech SE | 631 |
50 |
| Pfizer Inc. | 3351 |
49 |
| Centre National de La Recherche Scientifique | 10253 |
49 |
| The Brigham and Women's Hospital, Inc. | 2156 |
47 |
| Ohio State Innovation Foundation | 2071 |
46 |
| The Trustees of the University of Pennsylvania | 4282 |
44 |
| The University of North Carolina at Chapel Hill | 2011 |
42 |
| Mayo Foundation for Medical Education and Research | 3158 |
41 |
| Acuitas Therapeutics Inc. | 106 |
41 |
| Autres propriétaires | 6887 |